Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague.
Vaccine and therapeutic strategies that prevent infections with Yersinia pestis have been sought for over a century. Immunization with live attenuated (nonpigmented) strains and immunization with subunit vaccines containing recombinant low-calcium-response V antigen (rLcrV) and recombinant F1 (rF1) antigens are considered effective in animal models. Current antiplague subunit vaccines in development for utilization in humans contain both antigens, either as equal concentrations of the two components (rF1 plus rLcrV) or as a fusion protein (rF1-rLcrV). Here, we show that immunization with either purified rLcrV (a protein at the tip of type III needles) or a variant of this protein, recombinant V10 (rV10) (lacking amino acid residues 271 to 300), alone or in combination with rF1, prevented pneumonic lesions and disease pathogenesis. In addition, passive immunization studies showed that specific antibodies of macaques immunized with rLcrV, rV10, or rF1, either alone or in combination, conferred protection against bubonic plague challenge in mice. Finally, we found that when we compared the reactivities of anti-rLcrV and anti-rV10 immune sera from cynomolgus macaques, BALB/c mice, and brown Norway rats with LcrV-derived peptides, rV10, but not rLcrV immune sera, lacked antibodies recognizing linear LcrV oligopeptides.
Cornelius
Claire A
CA
Department of Microbiology, University of Chicago, Chicago, Illinois 60637, USA.
Quenee
Lauriane E
LE
Overheim
Katie A
KA
Koster
Frederick
F
Brasel
Trevor L
TL
Elli
Derek
D
Ciletti
Nancy A
NA
Schneewind
Olaf
O
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D008168:Lung / Q000276:immunology / Q000473:pathology; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008992:Monkey Diseases / Q000276:immunology / Q000517:prevention & control; D010930:Plague / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D010931:Plague Vaccine / Q000276:immunology*; D052899:Pore Forming Cytotoxic Proteins / Q000276:immunology; D051381:Rats; D011994:Recombinant Proteins / Q000276:immunology; D022223:Vaccines, Subunit / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D015010:Yersinia pestis
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; C043908:LcrV protein, Yersinia; D010931:Plague Vaccine; D052899:Pore Forming Cytotoxic Proteins; D011994:Recombinant Proteins; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; C086725:caf1 protein, Yersinia pestis
Microbes Infect. 2000 Jan;2(1):25-31
10717537
Infect Immun. 2008 May;76(5):2025-36
18347051
Infect Immun. 1996 Oct;64(10):4313-8
8926104
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91
16306265
N Engl J Med. 1997 Sep 4;337(10):677-80
9278464
Bull World Health Organ. 1960;23:408-9
13845309
JAMA. 2000 May 3;283(17):2281-90
10807389
Vaccine. 2007 Apr 20;25(16):3014-7
17287055
Am J Pathol. 1969 Feb;54(2):167-85
4974722
J Immunol Methods. 1990 Sep 14;132(2):191-5
2170533
Emerg Infect Dis. 2002 Mar;8(3):311-6
11927030
J Infect Dis. 1959 Jan-Feb;104(1):78-84
13631290
Infect Immun. 1993 Jan;61(1):23-31
8418045
Antimicrob Agents Chemother. 2006 Oct;50(10):3233-6
17005799
Infect Immun. 1994 Oct;62(10):4192-201
7927675
Infect Immun. 2005 Sep;73(9):6127-37
16113334
Adv Exp Med Biol. 2007;603:415-24
17966437
Infect Immun. 2005 Mar;73(3):1532-42
15731051
Infect Immun. 1995 Aug;63(8):3021-9
7622225
Expert Rev Vaccines. 2008 Mar;7(2):209-21
18324890
J Hyg (Lond). 1914 Jan;13(Suppl):423-39
20474555
Comp Med. 2008 Feb;58(1):68-75
19793459
Nature. 1956 Mar 3;177(4505):426-7
13309325
Bull World Health Organ. 1970;42(5):653-66
4988692
Vaccine. 1997 Jul;15(10):1079-84
9269050
Science. 2007 Jan 26;315(5811):509-13
17255510
J Immunol. 1952 Feb;68(2):131-45
14927919
Infect Immun. 1986 Nov;54(2):428-34
3021629
Vaccine. 2000 Oct 15;19(4-5):566-71
11027822
Vaccine. 2001 Jul 20;19(30):4175-84
11457543
Infect Immun. 1995 Aug;63(8):2854-8
7622205
Vaccine. 1998 Jul;16(11-12):1131-7
9682370
Am J Public Health (N Y). 1920 Jul;10(7):599-605
18010342
Lancet. 2000 Jan 8;355(9198):111-3
10675169
Science. 1992 Nov 6;258(5084):1004-7
1439793
Clin Vaccine Immunol. 2007 May;14(5):605-16
17376861
Clin Vaccine Immunol. 2008 Jul;15(7):1134-7
18480233
J Infect Dis. 1957 May-Jun;100(3):215-22
13439204
J Bacteriol. 2002 Aug;184(16):4601-11
12142430
Bacteriol Rev. 1961 Sep;25:249-61
14473142
Arch Intern Med. 1992 Jun;152(6):1253-6
1599354
Methods Enzymol. 1990;185:60-89
2199796
J Med Entomol. 1993 Jul;30(4):758-61
8395603
J Infect Dis. 1974 May;129:Suppl:S41-5
4825248
J Immunol. 1984 Oct;133(4):2226-30
6381597
Arch Pathol Lab Med. 1996 Feb;120(2):156-63
8712895
Infect Immun. 2005 Aug;73(8):5152-9
16041032
Contrib Microbiol Immunol. 1995;13:325-8
8833864
Vaccine. 1995 Nov;13(16):1551-6
8578841
Br J Exp Pathol. 1958 Jun;39(3):278-91
13546547
J Immunol. 2002 Feb 1;168(3):1315-21
11801671
Clin Infect Dis. 2000 Jun;30(6):893-900
10852811
Infect Immun. 1996 Nov;64(11):4580-5
8890210
Infect Immun. 2003 Jul;71(7):3673-81
12819047
Ann Trop Med Parasitol. 2005 Dec;99(8):789-93
16297292
Infect Immun. 1997 Nov;65(11):4476-82
9353022
J Commun Dis. 2006 Dec;38(4):317-24
17913207
Infect Immun. 2006 Aug;74(8):4910-4
16861680
Infect Immun. 1996 Jun;64(6):2180-7
8675324
Am J Trop Med Hyg. 2003 Oct;69(4):450-1
14640508
Infect Immun. 2005 Jun;73(6):3598-608
15908389
Immunology. 2006 Nov;119(3):385-92
16919002
Science. 2004 Apr 30;304(5671):736-8
15118163
J Exp Med. 2002 Oct 21;196(8):1017-24
12391013
Am J Trop Med Hyg. 1994 Jul;51(1):109-14
8059908
Mol Microbiol. 1999 Jun;32(5):961-76
10361299
Science. 2005 Oct 28;310(5748):674-6
16254184
Infect Immun. 2007 Jul;75(7):3571-80
17438030